A& Tax Managing Director Dan Peters was recently featured in Bloomberg Tax's article, 'Trump Pharma Pricing Order Piles on Transfer Pricing'. This article outlines President Donald Trump's executive order related to lowering US medicine prices and explores its implications for transfer pricing and existing tariff policies.
"It’s the latest in a series of things causing pharmaceutical companies to reconsider all aspects of their international tax planning and their transfer pricing, and even further, how they organize their supply chain.”
Mr. Peters provides his perspective on the order, commenting on its anticipated effects on pharmaceutical company's international tax planning and supply chain organization.
Read The Full Article
India Tax Alert | Supreme Court Clarifies Taxability on Amalgamation: The “Commercial Realizability” Test
January 13, 2026
In a landmark ruling, the Supreme Court has introduced the “commercial realizability” test to assess taxability in share substitution cases, holding that freely marketable shares with definite commercial value may give rise to taxable business income.
A&M Tax – Monthly Recap of EU and Dutch Tax Developments
January 13, 2026
The “Monthly Recap” is A&M’s monthly newsletter providing a concise overview of EU and Dutch tax developments.
Mexican General Tax Rules for 2026: Changes Applicable to the Financial Sector
January 12, 2026
Overview of MFRL 2026 reforms impacting MITL, VATL, credit institutions, insurers, and capital repatriation compliance in Mexico.
New Hampshire Tax Amnesty Program Provides an Excellent, Limited Time Opportunity to Resolve Prior Period Liabilities
January 7, 2026
A limited-time New Hampshire tax amnesty program offers meaningful relief for unresolved state tax liabilities. The opportunity closes February 15, 2026.
